This inventor holds 1 USPTO granted patent. Top assignees: National Institute of Health and Medical Research, Queen's University at Kingston. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,853 
1 out of 425 
Years Active: 2022
Title: Caitlin Miron: Innovator in Cancer Research
Introduction
Caitlin Miron is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of cancer research through her innovative work on platinum compounds. Her research focuses on the binding of guanine quadruplexes, which are structures formed by DNA or RNA.
Latest Patents
Caitlin Miron holds a patent for "Platinum compounds for binding guanine quadruplexes." This patent describes and characterizes compounds that effectively bind to guanine quadruplexes of DNA or RNA. The binding data and inhibition of growth data of five cancer cell lines are presented, showcasing the potential of these compounds in cancer treatment.
Career Highlights
Throughout her career, Caitlin has worked with esteemed institutions such as Queen's University at Kingston and the Institut National de la Santé et de la Recherche Médicale. Her work has been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.
Collaborations
Caitlin has collaborated with notable colleagues, including Anne Petitjean and Jean-Louis Mergny. These partnerships have enriched her research and contributed to the success of her projects.
Conclusion
Caitlin Miron is a dedicated inventor whose work in cancer research has the potential to make a significant impact on treatment options. Her innovative approach to binding guanine quadruplexes highlights her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile